Immutep Limited Gains 40.77%
Tue 14 Apr 20 at 05:30 PM
Immutep Limited (IMMP:NASDAQ) soared at $1.08, representing a gain of 40.8%. On Mon 13 Apr 20, IMMP:NASDAQ touched a New 2-Week High of $0.77. The stock appeared on our News Catalysts scanner on Wed 08 Apr 20 at 08:55 AM in the 'BIOTECH' category. From Mon 30 Mar 20, the stock recorded 44.44% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Immutep Limited (IMMP:NASDAQ)
Immutep Ltd, formerly Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe.
Top 10 Gainers:
- Obalon Therapeutics, Inc. (OBLN:NASDAQ), 139.71%
- ReWalk Robotics Ltd. (RWLK:NASDAQ), 61.9%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 61.74%
- NeuroMetrix, Inc. (NURO:NASDAQ), 58.73%
- MEI Pharma, Inc. (MEIP:NASDAQ), 49.7%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 47.06%
- MicroVision, Inc. (MVIS:NASDAQ), 44.68%
- Forestar Group Inc. (FOR:NYSE), 42.17%
- Immutep Limited (IMMP:NASDAQ), 40.77%
- RigNet, Inc. (RNET:NASDAQ), 38.79%